Your browser doesn't support javascript.
loading
Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.
Glykofridis, Iris E; Knol, Jaco C; Balk, Jesper A; Westland, Denise; Pham, Thang V; Piersma, Sander R; Lougheed, Sinéad M; Derakhshan, Sepide; Veen, Puck; Rooimans, Martin A; van Mil, Saskia E; Böttger, Franziska; Poddighe, Pino J; van de Beek, Irma; Drost, Jarno; Zwartkruis, Fried Jt; de Menezes, Renee X; Meijers-Heijboer, Hanne Ej; Houweling, Arjan C; Jimenez, Connie R; Wolthuis, Rob Mf.
Afiliación
  • Glykofridis IE; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Knol JC; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Balk JA; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Westland D; University Medical Center Utrecht, Center for Molecular Medicine, Molecular Cancer Research, Universiteitsweg, Utrecht, Netherlands.
  • Pham TV; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Piersma SR; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Lougheed SM; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Derakhshan S; Princess Máxima Center for Pediatric Oncology, Oncode Institute, Heidelberglaan, Utrecht, Netherlands.
  • Veen P; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Rooimans MA; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • van Mil SE; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Böttger F; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Poddighe PJ; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Amsterdam, Netherlands.
  • van de Beek I; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Amsterdam, Netherlands.
  • Drost J; Princess Máxima Center for Pediatric Oncology, Oncode Institute, Heidelberglaan, Utrecht, Netherlands.
  • Zwartkruis FJ; University Medical Center Utrecht, Center for Molecular Medicine, Molecular Cancer Research, Universiteitsweg, Utrecht, Netherlands.
  • de Menezes RX; NKI-AvL, Biostatistics Unit, Amsterdam, Netherlands.
  • Meijers-Heijboer HE; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Houweling AC; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Amsterdam, Netherlands.
  • Jimenez CR; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Wolthuis RM; Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Clinical Genetics, Cancer Center Amsterdam, Amsterdam, Netherlands.
Elife ; 102021 01 18.
Article en En | MEDLINE | ID: mdl-33459596
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Portadoras / Proteínas Proto-Oncogénicas / Proteínas Supresoras de Tumor / Células Epiteliales / Riñón Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Portadoras / Proteínas Proto-Oncogénicas / Proteínas Supresoras de Tumor / Células Epiteliales / Riñón Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos